Nikos Werner
Latest contributions
Expanding the horizon - Trials addressing unchartered territories in coronary and structural heart
20 May 2026 – From EuroPCR 2026
New clinical evidence is pushing coronary and structural heart therapy into areas that were previously uncertain or inconsistently defined, with multiple landmark trials now shaping future practice.
Among the studies discussed in this EuroPCR 2026 session, are SORT OUT XII, START YOUNG, BISCUSPID, LANDMARK 2 and RESTORE...
Rethinking stentless PCI strategy - Improving outcomes with Bioadaptor
19 May 2026 – From EuroPCR 2026
This EuroPCR 2026 session explores contemporary PCI strategies through the concept of stentless intervention using the Bioadaptor device in complex coronary disease.
It highlights the bioadaptive design features of Bioadaptor and reviews the supporting clinical evidence, with a focus on how this technology may influence procedural outcomes.
The...
Align for the future with next gen Myval transcatheter heart valve series
16 Nov 2025 – From PCR London Valves 2025
Discover how the latest Myval transcatheter heart valve (THV) innovations are shaping TAVI outcomes. This PCR London Valves 2025 session highlights the clinical evidence behind the next-gen Myval THV series, best practices for implantation, and upcoming innovations set to improve patient care. Learn step-by-step techniques for deploying Myval...
Clinical impact of mechanical circulatory support
22 May 2025 – From EuroPCR 2025
Explore the clinical impact of mechanical circulatory support through a series of detailed presentations covering protocols and training effects on outcomes in left-sided micro-axial flow-supported shock patients, practice variations between Sweden and the U.S., six-month outcomes post coronary intervention with VA-ECMO, and the prognostic value of...
Advancing the standard of care in PCI with Bioadaptor: from simple to complex
21 May 2025 – From EuroPCR 2025
This session provides an in-depth overview of Bioadapter technology and its potential to overcome the limitations of current drug-eluting stents (DES) in percutaneous coronary intervention (PCI). Speakers present data from recent trials, including the Bioadapter RCT and the Infinity Sweetheart study, demonstrating a reduction in target lesion...
Native TAVI in small annulus with low coronary take-off - Lifetime management
27 Jul 2023
Analyze the case of this 78-year-old female patient with diabetes, obesity, HTN and hyperlipidemia, who presented with severe symptomatic AS, severely calcified posterior mitral leaflet, and both mild mitral and tricuspid regurgitations, and tell us how you would treat this woman!
Author
Revascularisation in patients with depressed left ventricular ejection fraction
18 May 2023 – From EuroPCR 2023
In these slides, delve into recent evidence and identify potential beneficiaries for revascularisation, while exploring safety strategies for PCI in cases of reduced left ventricular ejection fraction.
Stroke prevention in TAVI
21 Nov 2021 – From PCR London Valves 2021
In this PCR London Valves 2021 session, learn about the standard use of the cerebral embolism protection device in routine TAVR, find out more about the PROTEMBO C trial, and take a close look at the TriGUARD 3 device.
